Financial Performance - In 2018, the company's operating revenue reached ¥2,191,465,177.73, representing a growth of 37.88% compared to ¥1,589,421,937.70 in 2017[20]. - The net profit attributable to shareholders was ¥367,401,372.13, an increase of 28.45% from ¥286,035,336.33 in the previous year[20]. - The basic earnings per share rose to ¥2.19, marking a 26.59% increase from ¥1.73 in 2017[20]. - The net cash flow from operating activities surged by 509.23%, reaching ¥244,307,282.99, compared to a negative cash flow of ¥59,699,333.59 in 2017[20]. - Total assets increased by 40.71% to ¥3,229,574,444.83, up from ¥2,295,220,889.36 in 2017[20]. - The company achieved a consolidated revenue of 2.191 billion yuan in 2018, representing a year-on-year growth of 37.88%[41]. - Operating profit reached RMB 453,623,500, a 38.17% increase compared to RMB 328,319,200 from the previous year[49]. - Net profit attributable to shareholders was RMB 393,839,600, reflecting a 37.69% growth from RMB 286,035,300 in the prior year[49]. Dividend Policy - The company plans to distribute a cash dividend of 3 RMB per 10 shares to all shareholders, subject to approval at the shareholders' meeting[5]. - In 2016, the company distributed a cash dividend of 2 RMB per 10 shares, totaling 24,000,000 RMB, which represented 16.41% of the net profit attributable to ordinary shareholders[137]. - In 2017, the cash dividend increased to 3 RMB per 10 shares, totaling 36,000,000 RMB, accounting for 12.59% of the net profit attributable to ordinary shareholders[137]. - In 2018, the company maintained a cash dividend of 3 RMB per 10 shares, with a total distribution of 50,819,958 RMB, representing 13.83% of the net profit attributable to ordinary shareholders[137]. - The company plans to conduct cash dividends annually after the shareholders' meeting, based on profitability and funding needs[134]. Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[7]. - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report[6]. - The company faces risks related to safety production and environmental protection due to the nature of its pesticide production, which involves flammable, explosive, and toxic substances[126]. - Fluctuations in raw material prices and production instability pose risks to the company's pesticide raw material products, influenced by market demand and environmental pressures[128]. - The company is exposed to risks from upstream raw material supply and price volatility, which can significantly impact production costs and gross margins[129]. - The company will closely monitor changes in industry regulations and policies to ensure compliance and mitigate operational risks[131]. Research and Development - The company has been recognized as a "National Key High-tech Enterprise" and has established a strong R&D center since 2003[37]. - The company’s R&D expenses increased by 83.98% to RMB 90,684,326.68, indicating a strong focus on innovation[51]. - The company has developed new generations of neonicotinoid insecticides, further enhancing its product offerings and market position[36]. - The company aims to improve product quality and operational efficiency through a focus on quality management and innovation[123]. - The company plans to strengthen its international market expansion by enhancing product registration abroad and increasing export capabilities for formulations and active ingredients[120]. Environmental Compliance - The company has achieved compliance with emission standards for both waste gas and waste water during the reporting period[179]. - The total emissions of particulate matter, SO2, NOx, and VOCs are 5.9762 tons, 6.9708 tons, 12.5315 tons, and 38.87 tons per year respectively[184]. - The company has established an environmental management system certified to meet the ISO 14001:2004 standard[181]. - The company has implemented effective pollution control measures, including a wastewater treatment plant and various air pollution control devices[185]. - No significant violations of environmental laws or pollution incidents occurred during the reporting period[190]. Corporate Governance - The financial report has been audited by Zhongxinghua Certified Public Accountants, providing a standard unqualified opinion[4]. - The company has established a commitment to transparency and accountability regarding its IPO process and shareholder management[143]. - The company has made a long-term commitment to ensure that the IPO prospectus does not contain false records or misleading statements[143]. - The company has appointed Zhongxinghua Accounting Firm as the auditor for the 2018 fiscal year, with an audit fee of RMB 700,000[153]. - The company has implemented a restricted stock incentive plan, which was approved in a board meeting on January 22, 2018[154].

| 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 9 | 2018 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 2018 年第三季度报告 公司代码：603639 公司简称：海利尔 海利尔药业集团股份有限公司 2018 年第三季度报告 1 / 21 1.3 公司负责人葛家成、主管会计工作负责人方洁及会计机构负责人（会计主管人员）方洁保证 季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 3 / 21 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度 末增减(%) 总资产 2,922,452,211.51 2,295,220,889.36 27.33 归属于上市公司股东的 净资产 1, ...

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the first half of 2018, representing a year-on-year increase of 15%[13]. - The net profit attributable to shareholders was RMB 200 million, up 10% compared to the same period last year[13]. - The company's revenue for the first half of the year reached approximately ¥1.25 billion, representing a 50.45% increase compared to the same period last year[23]. - Net profit attributable to shareholders increased by 62.44% to approximately ¥240.49 million[23]. - The company achieved a consolidated revenue of CNY 1.249 billion in the first half of 2018, representing a year-on-year growth of 50.45%[38]. - The net profit attributable to the parent company reached CNY 240 million, an increase of 62.44% compared to the same period last year[38]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion in the first half of 2018, representing a 20% year-over-year growth[72]. - The company provided a positive outlook for the next quarter, projecting a revenue increase of 25% based on new product launches and market expansion strategies[74]. - The company reported a gross margin of 45%, indicating strong operational efficiency and cost management[74]. - Future guidance includes an expected EBITDA margin improvement to 30% by the end of the fiscal year, driven by operational efficiencies and cost-cutting measures[72]. Assets and Liabilities - The company’s total assets reached RMB 3.5 billion, with a current ratio of 1.5, indicating strong liquidity[13]. - The company reported a net cash flow from operating activities of approximately -¥36.32 million, a 43.96% improvement year-on-year[23]. - Cash and cash equivalents increased by 90.03% to $804.36 million, representing 29.18% of total assets[48]. - Accounts receivable rose by 112.19% to $591.50 million, accounting for 21.45% of total assets, attributed to seasonal sales[48]. - Inventory decreased by 25.65% to $282.36 million, making up 10.24% of total assets, due to a decline in stock during peak sales season[48]. - The company's total liabilities rose to ¥935,560,038.52 from ¥680,039,291.15, which is an increase of approximately 37.5%[129]. - The equity attributable to the owners of the parent company increased to ¥1,821,251,996.40 from ¥1,614,711,355.18, showing a growth of about 12.8%[130]. Research and Development - Research and development expenses accounted for 8% of total revenue, reflecting the company's commitment to innovation[13]. - Research and development expenses increased by 113.93% to CNY 36.44 million, reflecting a significant investment in innovation[46]. - The company plans to invest 200 million in research and development to drive technological advancements and improve product efficiency[72]. Market Expansion and Strategy - User data showed an increase in customer base by 20%, reaching 1 million active users[13]. - The company plans to launch three new pesticide products by the end of 2018, targeting a market share increase of 5%[13]. - The company is actively expanding its sales channels, including government procurement and cooperative farming initiatives[28]. - The overseas market is becoming a significant growth driver for the industry, with high-end generic drugs and intermediates expected to present good market opportunities[29]. - The company is actively expanding its overseas market presence, having obtained product registration in over 40 countries and currently pursuing registrations in more than 60 additional countries[36]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share within the next two years[73]. - A strategic acquisition was announced, with the company acquiring a competitor for 500 million, aimed at enhancing its product offerings and market reach[74]. Risk Management - The company has identified key risks including regulatory changes and market competition, with strategies in place to mitigate these risks[13]. - The company is facing risks related to safety production and environmental protection due to the nature of its operations involving hazardous materials[58]. - The company emphasizes safety production as a top priority, enhancing management systems and daily supervision to prevent accidents[59]. - The company faces significant price volatility in pesticide raw materials due to market demand, upstream petrochemical prices, and environmental pressures[60]. - The company is closely monitoring changes in industry regulations and policies that could impact its operations and compliance[63]. - Currency fluctuations pose risks to the company's export business, with a focus on mitigating these through hedging strategies[63]. Shareholder and Governance - The company has implemented an equity incentive plan, granting 1.39986 million shares at a price of CNY 15.97 per share to 52 participants[38]. - The company has not proposed any profit distribution or capital reserve increase for the half-year period[67]. - The actual controller and shareholders committed to not transferring or entrusting their shares for 36 months post-IPO, with an additional 24-month restriction on share reduction thereafter[69]. - The company has established a stock price stabilization plan to protect the interests of minority shareholders, which will be activated if the stock price falls below the net asset value per share within three years of the IPO[77]. - The company has renewed the appointment of Zhongxinghua Accounting Firm as the auditing institution for the 2018 fiscal year, approved at the annual shareholders' meeting on April 20, 2018[78]. - The company has implemented a restricted stock incentive plan, which was approved by the board on January 22, 2018[79]. Environmental Compliance - The company has implemented effective comprehensive treatment measures for waste water, waste gas, waste residue, and noise, achieving compliance with environmental discharge standards[90]. - The company holds an environmental management system certification that meets the GB/T24001-2004idtISO14001:2004 standard[90]. - The company has conducted environmental risk assessments and updated emergency response plans in accordance with regulations, with successful drills conducted[98]. - The company has not faced any significant violations of environmental laws or major pollution incidents during the reporting period[100]. Financial Reporting and Accounting - The financial report was approved by the board of directors on August 27, 2018, ensuring compliance with regulatory requirements[157]. - The company follows the enterprise accounting standards, ensuring that the financial reports accurately reflect its financial position and performance as of June 30, 2018[163]. - The company recognizes revenue based on specific accounting policies tailored to its operations in pesticide and water-soluble fertilizer production and sales[162]. - The company has established specific accounting treatments for business combinations, differentiating between those under common control and those not[167].

Dividend and Capital Distribution - The company plans to distribute a cash dividend of 3 RMB per 10 shares (including tax) to all shareholders based on the total share capital, with the remaining undistributed profits fully carried forward to the next year[6]. - The company will also increase capital by 4 shares for every 10 shares held, using capital reserves, subject to the balance of "capital reserve - share premium" as of the end of 2017[6]. - The company plans to distribute a cash dividend of 2 RMB per 10 shares, totaling 36 million RMB, based on a total share capital of 120 million shares for the year 2017[129]. - In 2016, the company distributed a cash dividend of 2 RMB per 10 shares, totaling 24 million RMB, with a net profit attributable to ordinary shareholders of 146.25 million RMB, resulting in a payout ratio of 16.41%[133]. Financial Performance - The company's operating revenue for 2017 was approximately ¥1.59 billion, representing a year-on-year increase of 54.98%[21]. - Net profit attributable to shareholders reached approximately ¥286 million, marking a significant increase of 95.58% compared to the previous year[21]. - The basic earnings per share rose to ¥2.43, reflecting a growth of 49.08% year-on-year[22]. - The weighted average return on equity decreased by 3.77 percentage points to 20.10% due to a substantial increase in net asset scale from fundraising[22]. - The net cash flow from operating activities showed a decline of 122.11%, primarily due to rising raw material prices and increased inventory[22]. - Total assets at the end of 2017 amounted to approximately ¥2.30 billion, a 92.88% increase from the previous year[21]. - The company's net assets increased by 140.13% to approximately ¥1.61 billion, driven by public stock issuance and profit contributions[22]. - The company achieved a consolidated revenue of 1.589 billion yuan, representing a year-on-year growth of 54.98%[46]. - The net profit attributable to shareholders reached 286 million yuan, an increase of 95.58% compared to the previous year[46]. - The gross profit margin for the pesticide segment increased by 1.68 percentage points to 39.04%[51]. Operational Highlights - The company continues to focus on the research, production, and sales of pesticides and fertilizers, with no significant changes in its main business operations[30]. - The pesticide industry experienced a rapid recovery in 2017, particularly in the raw material sector, with significant price increases for most products[29]. - The company implements a centralized procurement model for bulk raw materials, adjusting purchasing plans based on market price fluctuations[31]. - The company has a production capacity of 2,500 tons for Imidacloprid and 1,200 tons for Acetamiprid, with a complete self-sufficiency in intermediates, showcasing an integrated advantage in intermediates and active ingredients[36]. - The company established a professional sales team for herbicides, achieving sales of over 20 million yuan by the end of the reporting period[44]. - The company completed the construction of a 1,000-ton pyrazole ester project, which entered trial production in Q4 2017[44]. - The production of pesticide formulations increased by 74.06% year-on-year, while sales volume rose by 56.51%[53]. Research and Development - The company emphasizes R&D, having established a national-level technology center and recognized as a key laboratory for pesticide research by the Ministry of Agriculture[39]. - The company aims to enhance its research and development investment to focus on high-efficiency, low-toxicity, and environmentally friendly pesticide formulations, thereby achieving product differentiation[125]. - The company has increased its R&D investment and expanded its R&D center, focusing on high-efficiency, low-toxicity, and environmentally friendly pesticide formulations[168]. - The company has established leading brands in the pesticide industry, such as "Hailier" and "Aodis," and has been recognized as the most favored pesticide brand by Chinese farmers for seven consecutive years[168]. Environmental Compliance - The company achieved compliance with environmental discharge standards for both air and water pollutants during the reporting period[170]. - The company has established environmental monitoring plans and has not faced any significant environmental violations or pollution incidents[172]. - The company has implemented effective pollution control measures, including a range of facilities for air and wastewater treatment, which are operating normally[175]. - Shandong Hailier has received environmental management system certification in compliance with GB/T24001-2004 and ISO14001:2004 standards[173]. - The company achieved total emissions of 5.9762 tons/year for particulate matter, 6.9708 tons/year for SO2, 12.5315 tons/year for NOx, and 38.87 tons/year for VOCs, all within regulatory limits[175]. Shareholder Commitments and Governance - The actual controller and shareholders committed to not transferring or entrusting their shares for a period of 36 months post-IPO, with a further commitment not to reduce their holdings for two years thereafter[136]. - If the stock price falls below the IPO price for 20 consecutive trading days, the lock-up period will be automatically extended by 6 months[136]. - The company has made commitments regarding the absence of false statements or misleading information in its IPO prospectus, with potential buyback obligations if such issues are identified by regulatory authorities[139]. - The company will initiate compensation for investor losses within five working days if the IPO prospectus is found to contain false information or omissions[139]. - The company has established a stock price stabilization plan to protect the interests of minority shareholders and investors, which will be activated if the stock price falls below the net asset value per share[145]. Market and Competitive Landscape - The company is facing intense market competition with a low market concentration in the pesticide industry, leading to a reliance on price-based competition strategies[124]. - The pesticide industry is experiencing increased regulatory scrutiny, with new policies aimed at promoting sustainable practices and reducing the use of high-risk pesticides[109]. - The industry is shifting from product sales to value-added services, with a focus on integrated crop solutions and differentiated competition[110]. - The company aims to establish itself as a professional service platform for the entire agricultural supply chain, focusing on understanding and serving the needs of farmers[115]. Financial Management and Wealth Management - The company has entrusted a total of 372 million RMB in bank wealth management using idle raised funds, with an outstanding balance of 223 million RMB[159]. - The company has also invested 62 million RMB of its own funds in bank wealth management, with no outstanding balance[159]. - The annualized return rates for various bank wealth management products range from 2.9% to 5.1%, with the highest return achieved being 5.1%[162][163]. - The company has consistently recovered all invested amounts from wealth management products, indicating effective cash management strategies[162][163]. - The company plans to continue its wealth management strategy, leveraging bank partnerships to optimize returns on idle funds[162][163].

Financial Performance - Net profit attributable to shareholders increased by 47.55% to CNY 90,407,305.47 year-on-year[7] - Operating revenue rose by 44.59% to CNY 532,888,795.59 compared to the same period last year[7] - Basic earnings per share increased by 47.06% to CNY 0.75[7] - The company reported a significant increase in net profit and revenue, indicating strong business growth[7] - Net profit for the period was CNY 9,039.75 million, reflecting a 47.68% increase from CNY 6,121.26 million, attributed to higher operating income leading to increased gross profit[15] - Total operating revenue for Q1 2018 reached ¥532,888,795.59, a significant increase of 44.6% compared to ¥368,562,824.83 in the same period last year[28] - Net profit for Q1 2018 was ¥90,397,483.99, representing a 47.7% increase from ¥61,212,578.48 in Q1 2017[30] - The net profit for Q1 2018 was ¥29,851,049.90, an increase from ¥23,823,699.90 in the same period last year, representing a growth of approximately 25.5%[32] Assets and Liabilities - Total assets increased by 5.27% to CNY 2,416,095,970.05 compared to the end of the previous year[7] - Cash and cash equivalents increased by 50.63% to CNY 63,759.02 million from CNY 42,327.33 million, mainly due to higher dollar deposits[15] - Accounts receivable rose by 40.06% to CNY 39,042.29 million from CNY 27,875.79 million, influenced by seasonal sales increases[15] - The company's total liabilities rose to CNY 710,218.82 million from CNY 680,039.29 million, indicating increased leverage[22] - Total liabilities decreased to ¥338,463,200.78 from ¥356,934,390.46, indicating a reduction of approximately 5.2%[26] - Owner's equity increased to ¥1,108,576,399.60, up from ¥1,078,725,349.70, marking a growth of about 2.8%[26] Cash Flow - Net cash flow from operating activities improved by 25.48%, reaching CNY -62,531,724.56[7] - Cash inflow from operating activities totaled ¥343,476,605.21, compared to ¥227,921,917.70 in the previous year, reflecting a growth of about 50.6%[35] - Cash outflow from operating activities was ¥406,008,329.77, up from ¥311,838,987.66, resulting in a net cash flow from operating activities of -¥62,531,724.56, an improvement from -¥83,917,069.96 year-over-year[35] - Cash inflow from investment activities was ¥272,446,723.86, compared to ¥229,448,702.79 in the previous year, showing an increase of approximately 18.7%[35] - The net cash flow from investment activities was ¥227,388,184.90, significantly higher than ¥2,976,384.84 in the same period last year[35] - Cash inflow from financing activities was ¥82,120,368.98, down from ¥726,235,982.84, indicating a decrease of about 88.7%[36] - The net increase in cash and cash equivalents for the period was ¥221,105,822.05, compared to ¥577,241,664.06 in the previous year, a decline of approximately 61.6%[36] - The ending balance of cash and cash equivalents was ¥460,754,713.06, down from ¥784,767,138.25 year-over-year[36] Shareholder Information - The total number of shareholders reached 12,220[11] - The top shareholder, Zhang Aiying, holds 38.65% of the shares[11] Future Outlook - The company plans to continue expanding its market presence and investing in new product development to sustain growth[15] - The company plans to continue expanding its market presence and investing in new product development to sustain growth in the upcoming quarters[30] Other Financial Metrics - Non-recurring gains and losses amounted to CNY 1,997,738.84[9] - The weighted average return on equity decreased by 0.42 percentage points to 5.45%[7] - The company reported a 5,519.64% increase in financial expenses to CNY 2,815.20 million, largely due to foreign exchange gains and losses[15] - Total operating costs for Q1 2018 were ¥426,770,236.92, up 44.3% from ¥295,722,092.36 year-over-year[29] - Basic and diluted earnings per share for Q1 2018 were both ¥0.75, compared to ¥0.51 in the previous year, reflecting a 47.1% increase[30] - The company reported an investment income of ¥2,017,839.13 for Q1 2018, compared to ¥1,525,459.69 in the same period last year, showing a growth of 32.3%[29] - The company’s cash and cash equivalents were not explicitly detailed, but the total current assets were reported at ¥1,116,718,265.51, slightly up from ¥1,114,859,064.91[26] - The company received tax refunds of ¥15,431,068.32, compared to ¥6,373,072.38 in the previous year, marking an increase of approximately 142.1%[35]

Dividend and Capital Distribution - The company plans to distribute a cash dividend of 3 RMB per 10 shares (including tax) to all shareholders based on the total share capital, with the remaining undistributed profits carried forward to the next year[6]. - The company will also increase its capital by issuing 4 additional shares for every 10 shares held, using the capital reserve, subject to the balance of "capital reserve - share premium" as of the end of 2017[6]. - The company plans to distribute a cash dividend of 2 RMB per 10 shares, totaling 36 million RMB, based on a total share capital of 120 million shares for the year 2017[129]. - In 2016, the company distributed a cash dividend of 2 RMB per 10 shares, totaling 24 million RMB, with a net profit attributable to ordinary shareholders of 146.25 million RMB, resulting in a payout ratio of 16.41%[133]. Financial Performance - The company's operating revenue for 2017 was approximately ¥1.59 billion, representing a year-on-year increase of 54.98%[21]. - Net profit attributable to shareholders reached approximately ¥286 million, marking a significant increase of 95.58% compared to the previous year[21]. - The basic earnings per share rose to ¥2.43, reflecting a growth of 49.08% year-on-year[22]. - The weighted average return on equity decreased by 3.77 percentage points to 20.10% due to a substantial increase in net asset scale from fundraising[22]. - The net cash flow from operating activities showed a decline of 122.11%, resulting in a negative cash flow of approximately ¥59.7 million, primarily due to rising raw material prices and increased inventory[22]. - The company's total assets increased by 92.88% to approximately ¥2.30 billion, driven by the public offering of shares and profit contributions[21]. - The net assets attributable to shareholders grew by 140.13% to approximately ¥1.61 billion, largely due to the funds raised from the public offering[21]. - The company achieved a consolidated revenue of 1.59 billion yuan, representing a year-on-year growth of 54.98%[46]. - The net profit attributable to shareholders reached 286 million yuan, an increase of 95.58% compared to the previous year[46]. - The gross profit margin improved by 1.15 percentage points, with the overall gross profit margin at 37.28%[51]. Operational Insights - The company operates in the pesticide industry, which has seen a rapid recovery, particularly in the raw material sector, with significant price increases for most products[29]. - The company focuses on the research, production, and sales of pesticide formulations, intermediates, and water-soluble fertilizers, maintaining a stable business model[30]. - The company implements a centralized procurement model for bulk raw materials, adjusting purchasing plans based on market price fluctuations and seasonal production needs[31]. - The company has a production capacity of 2,500 tons for Imidacloprid and 1,200 tons for Acetamiprid, with a complete self-sufficiency in intermediates at 2,500 tons[36]. - The company has expanded its overseas market presence, obtaining support registrations for over 300 products in 30 countries, including Australia and Thailand[42]. - The company has invested in a new 1,000-ton production facility for Pyrazole Ester, which began trial production in Q4 2017[36]. - The company’s fixed assets increased by 148.7369 million yuan due to the investment in the Pyrazole Ester project[37]. - The company emphasizes a strong R&D capability, recognized as a national key high-tech enterprise and having established a post-doctoral research station[39]. - The company aims to enhance its integrated advantages in the pesticide industry by focusing on the synergy between formulations, active ingredients, and intermediates[38]. - The company plans to broaden its product range and strengthen its business channels to enhance overall competitiveness[42]. Market and Industry Trends - The agricultural chemical industry is experiencing a rapid recovery, with significant price increases for certain raw materials like Imidacloprid and Acetamiprid[33]. - The pesticide industry in China has over 2,000 production enterprises, indicating a low market concentration and significant potential for growth[105]. - The industry is shifting from product sales to value-added services, with a focus on integrated crop solutions and differentiated competition[110]. - New environmentally friendly pesticide products are expected to grow rapidly, driven by stricter regulations and increased public awareness of food safety and environmental protection[111]. - The industry is undergoing consolidation, with a target to have 2-3 large enterprises with international competitiveness by 2020, and 5 companies with sales over 50 billion yuan[112]. - The integration of agricultural inputs such as seeds, fertilizers, pesticides, and machinery is becoming a trend, promoting collaboration among companies to enhance service offerings[113]. Risk Management and Compliance - There are no significant risks that could materially affect the company's operations during the reporting period[8]. - The company has no non-operating fund occupation by controlling shareholders and their related parties[8]. - The company has no violations of decision-making procedures for providing guarantees to external parties[8]. - The company recognizes risks related to safety production and environmental protection, emphasizing the need for comprehensive management and preventive measures[121]. - The company faces price volatility risks in pesticide raw materials and aims to reduce production costs through technological improvements[123]. - The company will monitor raw material price fluctuations to inform operational decisions and maintain profitability[123]. - The company has implemented measures to hedge against foreign exchange risks as its export business grows, with a focus on USD pricing for its products[127]. - The company will actively monitor changes in national macro policies and industry regulations to mitigate risks associated with production and sales activities[126]. Corporate Governance and Shareholder Commitments - The actual controller and shareholders committed to not transferring or entrusting their shares for a period of 36 months post-IPO, with a further commitment not to reduce their holdings for two years thereafter[136]. - The company has established a clear timeline for the lock-up periods, with specific dates and durations outlined for compliance[136]. - The commitments made by the actual controller and shareholders are designed to ensure market stability and investor confidence post-IPO[136]. - The company has not engaged in any share buybacks during the reporting period, as indicated in the financial disclosures[135]. - The company has outlined specific reasons for not proposing a cash dividend despite positive earnings, which should be disclosed in detail[135]. - The company will require new directors and senior management to sign commitments to uphold the stock price stabilization promises made during the IPO[145]. - The company will initiate compensation procedures for investors within five working days if the prospectus is deemed misleading by regulatory authorities[139]. Environmental Responsibility - The company has implemented effective pollution control measures and has not faced any significant environmental violations or penalties during the reporting period[169]. - The company’s subsidiary, Shandong Hailier Chemical Co., is classified as a key pollutant discharge unit and has obtained environmental management system certification[169]. - The total emissions of major air pollutants from the company include 5.9762 tons of particulate matter, 6.9708 tons of SO2, and 12.5315 tons of NOx annually[171]. - The company has achieved compliance with wastewater discharge standards, with total COD emissions of 293.47 tons and ammonia nitrogen emissions of 14.6735 tons annually[171]. - The company has established a self-monitoring environmental plan in accordance with national regulations, ensuring transparency in pollution monitoring[173]. - The company is conducting feasibility studies for resource utilization projects, including a 3,000 tons/year project for producing steel casting agents[172]. - The company has implemented an emergency response plan for environmental incidents, which was reviewed and approved by local environmental experts[172]. Research and Development - Research and development expenses increased by 26.68% to 49.29 million yuan, reflecting the company's commitment to innovation[49]. - Research and development expenses totaled 49,291,506.04 CNY, representing 3.10% of total revenue, with 166 R&D personnel making up 11.18% of the total workforce[60]. - The company has increased its R&D investment and expanded its R&D center, focusing on the development of efficient, low-toxicity, and environmentally friendly pesticide formulations[168]. - The company aims to enhance its research and development investment to focus on high-efficiency, low-toxicity, and environmentally friendly pesticide formulations, thereby achieving product differentiation[125]. Shareholder Structure - The company has a total of 12,344 ordinary shareholders at the end of the reporting period[187]. - The largest shareholder, Zhang Aiying, holds 46,375,000 shares, representing 38.65% of the total shares[189]. - The second-largest shareholder, Ge Yaolun, holds 22,598,611 shares, accounting for 18.83% of the total shares[189]. - There are no significant shareholders holding more than 10% of the shares[198]. - The company has no controlling shareholder, with Zhang Aiying being the largest individual shareholder[193].

Financial Performance - Operating revenue for the first nine months reached CNY 1,150,090,324.88, a 33.11% increase from the same period last year[6] - Net profit attributable to shareholders increased by 37.94% to CNY 190,731,402.02 compared to the previous year[6] - Basic and diluted earnings per share were both CNY 1.63, reflecting a 5.84% increase year-over-year[7] - Revenue for the quarter reached RMB 115,009.03 million, a 33.11% increase compared to the same period last year[13] - Net profit increased by 37.87% to RMB 19,043.76 million, primarily due to higher operating income[13] - Total operating revenue for Q3 2017 reached ¥319,676,145.74, an increase of 45.7% compared to ¥219,176,444.67 in Q3 2016[24] - Year-to-date operating revenue for 2017 was ¥1,150,090,324.88, up 33.2% from ¥864,012,791.78 in the same period last year[24] - Net profit for Q3 2017 was ¥60,239,640.84, compared to ¥40,519,955.14 in Q3 2016, reflecting a growth of 48.5%[24] - The net profit attributable to the parent company for Q3 2017 was approximately ¥42.68 million, up from ¥32.93 million in Q3 2016, representing a 29% increase[25] - The total comprehensive income for Q3 2017 was approximately ¥42.40 million, compared to ¥32.79 million in Q3 2016, reflecting a 29% increase[27] Assets and Liabilities - Total assets increased by 68.59% to CNY 2,006,158,047.79 compared to the end of the previous year[6] - Total assets as of September 30, 2017, were ¥1,308,462,873.72, up from ¥799,924,628.95 at the beginning of the year[22] - Total liabilities decreased to ¥235,828,827.30 from ¥427,835,057.15 at the start of the year, indicating a reduction of 44.9%[22] - Shareholders' equity increased significantly to ¥1,072,634,046.42 from ¥372,089,571.80 at the beginning of the year, marking a growth of 187.5%[22] - Other non-current assets surged by 951.2% to RMB 56,741.59 million, mainly due to prepaid land and project payments[12] Cash Flow - Cash flow from operating activities showed a negative net amount of CNY -138,549,190.46, a decline of 278.54% compared to the previous year[6] - The net cash flow from operating activities was -138,549,190.46 RMB, compared to a positive cash flow of 77,602,540.37 RMB in the previous year[28] - Total cash inflow from investment activities was 1,258,670,229.03 RMB, significantly higher than 227,235,353.33 RMB in the same period last year[29] - The net cash flow from investment activities was -495,045,441.85 RMB, compared to -19,704,186.99 RMB in the previous year[29] - Cash inflow from financing activities totaled 726,650,367.31 RMB, with a net cash flow of 670,839,680.95 RMB, compared to -48,635,601.00 RMB last year[29] - The total cash and cash equivalents at the end of the period was 230,590,003.30 RMB, up from 98,315,715.70 RMB at the end of the previous year[29] - The cash outflow for investment activities was 1,753,715,670.88 RMB, significantly higher than 246,939,540.32 RMB in the previous year[29] - The net increase in cash and cash equivalents was 23,064,529.11 RMB, compared to 9,625,115.05 RMB in the previous year[29] Shareholder Information - The total number of shareholders reached 13,217 by the end of the reporting period[10] - The top shareholder, Zhang Aiying, holds 38.65% of the shares, totaling 46,375,000 shares[10] Project Developments - The construction of the pyraclostrobin project has been completed, with production expected to commence soon[13] - The company is actively forming a sales team for the water-soluble fertilizer project, which has completed its main construction[13] Costs and Expenses - Financial expenses rose significantly by 6,587.43% to RMB 1,486.11 million due to rapid appreciation of the RMB against the USD[13] - Total operating costs for Q3 2017 were ¥264,769,952.90, a rise of 45.2% from ¥182,337,201.26 in Q3 2016[24] - Year-to-date total operating costs for 2017 amounted to ¥916,728,864.53, an increase of 31.7% compared to ¥695,929,209.38 in the previous year[24] - The company reported an increase in sales costs, which rose to approximately ¥100.84 million in Q3 2017 from ¥62.41 million in Q3 2016, reflecting a 61% increase[26]

Financial Performance - The company's operating revenue for the first half of 2017 was CNY 830,414,179.14, representing a 28.78% increase compared to CNY 644,836,347.11 in the same period last year[21]. - The net profit attributable to shareholders for the first half of 2017 was CNY 148,047,104.00, a 40.54% increase from CNY 105,343,498.74 in the previous year[21]. - Basic earnings per share for the first half of 2017 were CNY 1.29, up 10.26% from CNY 1.17 in the same period last year[22]. - The net profit growth of 39.97% was in line with expectations, driven by favorable sales performance and lower expense growth[22]. - The company achieved a consolidated revenue of 830.41 million RMB in the first half of 2017, representing a year-on-year growth of 28.79%[34]. - The net profit attributable to the parent company reached 148 million RMB, marking a 40.85% increase compared to the same period last year[34]. - The total profit for the first half of 2017 was ¥182,862,536.00, up 36.1% from ¥134,253,171.97 in the same period last year[105]. Cash Flow and Financial Position - The net cash flow from operating activities was negative at CNY -64,808,713.02, a decrease of 226.30% compared to CNY 51,312,332.60 in the same period last year[21]. - Cash and cash equivalents increased by CNY 166,853,400, attributed to funds raised from the company's initial public offering[30]. - The company’s cash flow from operating activities showed a net outflow of 64.81 million RMB, a significant decrease compared to the previous year[36]. - Total cash inflow from operating activities amounted to 494,411,934.78 RMB, while cash outflow was 559,220,647.80 RMB, resulting in a net cash flow deficit[111]. - The total cash and cash equivalents at the end of the period were 365,005,307.24 RMB, an increase from 207,525,474.19 RMB at the beginning of the period[112]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 1,984,855,125.15, a 66.80% increase from CNY 1,189,971,133.45 at the end of the previous year[21]. - The net assets attributable to shareholders increased by 119.69% to CNY 1,477,212,206.85 from CNY 672,418,639.35 at the end of the previous year[21]. - Total current assets increased to CNY 1,500,553,360.28 from CNY 791,982,655.04, representing a growth of approximately 89.3%[96]. - Total liabilities decreased slightly to CNY 507,250,227.80 from CNY 517,150,574.85, a reduction of about 1.7%[98]. - Owner's equity surged to CNY 1,477,604,897.35 from CNY 672,820,558.60, marking an increase of approximately 119.8%[98]. Market and Industry Insights - The pesticide industry showed signs of recovery, with significant price increases for key raw materials such as imidacloprid and acetamiprid[27]. - The company’s sales model includes both domestic and international channels, with a focus on direct exports and flexible pricing strategies[29]. - The company is actively expanding its market presence both domestically and internationally while enhancing its product differentiation through R&D[49]. Research and Development - The company maintains a strong R&D capability, recognized as a key high-tech enterprise under the National Torch Program[31]. - The company’s R&D expenditure increased by 8.47% to 17.03 million RMB, reflecting ongoing investment in product development[36]. - The company has implemented an integrated strategy for formulations, raw materials, and intermediates, enhancing its risk resistance and profitability[31]. Shareholder and Capital Structure - The company issued 30 million shares at a premium, significantly increasing its net assets and total assets[22]. - The actual controller and shareholders have committed to not transferring shares for 36 months post-IPO, with a further 24-month restriction on share reduction after the lock-up period[55]. - Major shareholders, including Zhang Aiying and Ge Yaolun, have pledged to limit share reductions to 25% of their holdings annually for two years after the lock-up period[62]. - The company reported a total share capital increase from 90 million shares to 120 million shares after the issuance of 30 million new shares[81]. Environmental and Safety Compliance - The company is classified as a key pollutant discharge unit according to the 2016 environmental information disclosure list published by Weifang Environmental Protection Bureau[73]. - The company has implemented effective comprehensive treatment measures for wastewater, waste gas, waste residue, and noise, and has obtained the Environmental Management System Certification[73]. - The company has established a dedicated environmental management team and monitoring station to oversee environmental protection and safety production tasks[74]. Risk Management - There were no significant risks that materially affected the company's operations during the reporting period[7]. - The company is facing risks related to safety production and environmental protection due to the nature of its agricultural chemical production, which involves hazardous materials[48]. - The company is exposed to price volatility of raw materials and production instability, which can impact profitability; measures include increasing R&D investment and monitoring raw material prices[48]. Corporate Governance - The company appointed new management, including Ge Jiacheng as General Manager and Yang Botao as Deputy General Manager, during the board meeting on March 27, 2017[90]. - The company has not experienced any changes in controlling shareholders or actual controllers during the reporting period[88]. - The company has established a wholly-owned subsidiary, Qingdao Tengrunxiang Testing and Evaluation Co., Ltd., with a registered capital of 50 million RMB, focusing on analysis and safety evaluation of various products[43]. Accounting and Financial Reporting - The financial statements are prepared based on the going concern principle, indicating no significant issues affecting the company's ability to continue operations for at least 12 months from the reporting date[131]. - The company adheres to the accounting standards set by the Ministry of Finance, ensuring that the financial statements accurately reflect its financial position and operating results[132]. - The company recognizes foreign currency transactions at the exchange rate published by the People's Bank of China on the transaction date, with exchange differences recorded in the current period's profit or loss[145].

海利尔药业集团股份有限公司 2017 年第一季度报告 1 / 18 | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 8 | 2017 年第一季度报告 一、 重要提示 2017 年第一季度报告 公司代码：603639 公司简称：海利尔 二、 公司基本情况 2.1 主要财务数据 单位：元 币种：人民币 | | 本报告期末 | 上年度末 | 本报告期末比上年度末增 | | | --- | --- | --- | --- | --- | | | | | 减(%) | | | 总资产 | 1,949,574,974.16 | 1,189,971,133.45 | | 63.83 | | 归属于上市公司股 | 1,414,421,916.62 | 672,418,639.35 | | 110.35 | | 东的净资产 | | | | | | | 年初至报告期末 | 上年初至上年报告期末 | 比上年同期增减(%) | | | 经营活动产生的现 | -83,917,069.96 | 16,159,8 ...

Financial Performance - The company's operating revenue for 2016 was CNY 1,025,552,512.84, representing a 0.91% increase compared to CNY 1,016,310,433.67 in 2015[20]. - The net profit attributable to shareholders for 2016 was CNY 146,251,394.70, which is a 12.10% increase from CNY 130,461,490.49 in 2015[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 140,895,769.75, representing a 6.00% increase compared to CNY 132,922,220.66 in the previous year[21]. - The net cash flow from operating activities increased by 110.42% to CNY 270,060,029.69, attributed to a significant increase in advance receipts and a decrease in accounts receivable[22]. - Total assets reached CNY 1,189,971,133.45, a 35.21% increase from CNY 880,097,443.55 in the previous year, driven by increases in cash, construction in progress, and intangible assets[22]. - Basic earnings per share rose to CNY 1.63, a 12.41% increase from CNY 1.45 in 2015[22]. - The company reported quarterly revenues of CNY 285,929,305.39 in Q1, CNY 358,907,041.72 in Q2, CNY 219,176,444.67 in Q3, and CNY 161,539,721.06 in Q4[24]. - The net profit attributable to shareholders in Q4 was CNY 7,982,166.80, a significant decrease compared to previous quarters[24]. - The company achieved a consolidated revenue of CNY 1.026 billion, representing a year-on-year growth of 0.91%[43]. - The net profit attributable to the parent company was CNY 146 million, reflecting a year-on-year increase of 12.10%[43]. - The total revenue for the year was 655,017,760.69 CNY, a decrease of 1.74% compared to the previous year[53]. - The company reported a total of CNY 4,283,253.85 in long-term equity investments, up from CNY 3,557,000.44, indicating a growth of about 20.4%[193]. - The company reported a total of CNY 30 million in December 2016, with a 4.15% interest rate on its financial products[136]. Dividend Policy - The profit distribution plan for 2016 proposes a cash dividend of CNY 2 per 10 shares, based on a total share capital of 120,000,000 shares[5]. - The company plans to distribute cash dividends of 3 RMB per 10 shares based on the total share capital of 90 million shares, amounting to a total cash distribution of 27 million RMB for the year 2016[117]. - The cash dividend distribution ratio for 2016 is 20.70% of the net profit attributable to ordinary shareholders, which is 130.46 million RMB[118]. - The company has a fixed cash dividend policy, distributing no less than 10% of the distributable profit in a single year, subject to certain conditions[116]. - The company has committed to maintaining a cash dividend policy that ensures normal operations and long-term development, with potential mid-term cash dividends based on profitability and funding needs[117]. - The company’s cash dividend distribution is contingent upon receiving an unqualified audit report for the financial year[116]. - The company has a structured approach to dividend distribution, ensuring that any prior losses are accounted for before determining the distributable profit[116]. Risks and Challenges - The company has no significant risks that could materially affect its operations during the reporting period[7]. - The company has outlined various risks and countermeasures in its operational analysis section[7]. - The company faced challenges in market forecasting and inventory planning, leading to short-term supply shortages for some products[45]. - Price fluctuations in raw pesticide products and production instability pose significant risks, prompting the company to increase investment in technological improvements[112]. - The competitive landscape in the pesticide industry is intense, with many small players and low market concentration, leading to a focus on price competition[113]. - The company faces risks related to safety production and environmental protection, necessitating comprehensive management and preventive measures[111]. Research and Development - The company continues to focus on the research, production, and sales of environmentally friendly pesticide formulations and related raw materials, with no significant changes in its main business[31]. - The company has established a robust R&D capability, recognized as a national high-tech enterprise, with a comprehensive pesticide research center covering all aspects of pesticide development[40]. - The company’s research and development expenditure rose by 20.00% to CNY 38,911,258.49 from CNY 32,425,466.48[47]. - The company is focused on increasing its research and development capabilities to enhance its competitive edge in the pesticide market[106]. - The company continues to focus on the research and development of efficient, low-toxicity, and environmentally friendly pesticide formulations[141]. Market and Industry Trends - The company operates in the pesticide and chemical industry, focusing on agricultural solutions[11]. - The company has successfully registered over 200 products in more than 30 countries, including Australia, Thailand, and Bolivia, and is pursuing registrations in over 30 additional countries[41]. - The company emphasizes a strong integration strategy of formulations, active ingredients, and intermediates to enhance profitability and reduce cyclical risks[40]. - The company is responding to industry trends by focusing on high-efficiency, low-toxicity, and environmentally friendly products, indicating a shift towards innovation and quality[36]. - The domestic pesticide industry has a low concentration, with over 2,000 companies, indicating significant room for improvement in market consolidation[103]. - The agricultural sector is expected to see a reduction in the number of pesticide raw material companies by 30% by 2020, aiming for a more concentrated market[104]. - The pesticide industry aims for over 70 new pesticide varieties to be created by 2020, with R&D expenses reaching over 5% of sales revenue for leading enterprises[68]. Corporate Governance and Compliance - The company has established a governance structure that includes a shareholders' meeting, board of directors, supervisory board, and senior management, ensuring clear responsibilities and effective operation[175]. - The company held four shareholders' meetings during the reporting period[177]. - The company has independent directors serving in various capacities, ensuring governance and oversight[166]. - The company has made commitments to comply with regulations regarding share reductions by major shareholders, ensuring transparency and adherence to legal requirements[123]. - The company’s commitment to maintaining shareholder stability and compliance with regulations reflects its focus on long-term growth and investor trust[123]. Environmental and Social Responsibility - The company has invested in environmental protection measures, achieving compliance with air and wastewater discharge standards[144][145]. - The company actively engaged in social responsibility initiatives, including charitable donations and employee volunteer activities[141]. - The company has not faced any environmental violations or major pollution incidents during the reporting period[145]. Employment and Workforce - The company employed 1,290 people, contributing to local employment and social stability[140]. - The total number of employees in the parent company is 390, while the total number of employees in major subsidiaries is 883, resulting in a combined total of 1,290 employees[170]. - The company has a salary policy that emphasizes strategic alignment and internal and external equity, aiming to motivate employees and enhance overall performance[171]. - The company conducts annual training plans based on employee needs, focusing on professional knowledge and skills[172].